| Financial Year |
March 31 2023 |
| Monetary Funds |
478,688,055.14 |
| Held-for-trading Financial Assets |
117,007,834.77 |
| Notes Receivable |
33,715,572.93 |
| Accounts Receivable |
382,462,233.12 |
| Advances to Suppliers |
58,720,827.17 |
| Other Receivables |
24,808,207.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
232,932,982.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
134,055,697.88 |
| Total Current Assets |
1,470,154,712.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,505,620.72 |
| Investment Properties |
240,626,540.60 |
| Fixed Assetes |
291,712,242.32 |
| Under-construction Projects |
19,689,548.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,207,522.92 |
| R&D expenses |
-- |
| Goodwill |
384,268,558.14 |
| Long-Term Deferred and Prepaid Expenses |
11,012,002.96 |
| Deferred Income Tax Assets |
28,529,229.88 |
| Other Non-Current Assets |
107,383,100.00 |
| Sub-Total of Non-Current Assets |
1,502,661,450.47 |
| Total Assets |
2,972,816,163.12 |
| Short-Term Loans |
110,257,010.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
127,518,018.24 |
| Accounts Payable |
176,614,182.71 |
| Accounts Received In Advance |
1,921,866.74 |
| Employee Compensation Payable |
36,094,350.92 |
| Taxes Payable |
12,563,687.12 |
| Interest Payable |
-- |
| Dividend Payable |
232,400.00 |
| Other payables |
169,144,697.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,466,400.04 |
| Other Current Liabilities |
4,113,997.82 |
| Sub-Total of Current Liabilities |
696,286,744.28 |
| Long-term Loans |
19,318,488.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,750.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
16,245,958.49 |
| Deferred Income Tax Liabilities |
59,230,609.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
130,622,916.81 |
| Total Liabilities |
826,909,661.09 |
| Paid-In Capital(Or Share Stock) |
515,294,257.00 |
| Capital Surplus |
1,626,230,320.94 |
| Surplus Reserve |
5,840,165.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-59,057,245.48 |
| Minority Stockholder's Interest |
13,744,276.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,132,162,225.27 |
| Owner's Equity（Stockholder's Equity） |
2,145,906,502.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,972,816,163.12 |
